Icosapent Ethyl

CAS 86227-47-6 10 current records 2 historicalSmall Molecule

Who holds supplier records for Icosapent Ethyl? 10 organisations hold a current record for Icosapent Ethyl: an active US FDA Type II Drug Master File. A further 2 organisations have only historical (inactive) DMF filings. Recorded organisation countries for current records: China (4), South (1), Norway (1), France (1) and 1 other country (1); not recorded for 2.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Icosapent Ethyl: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/icosapent-ethyl

Reading the evidence

  • 10 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 4 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

  • US product patents listed

    The latest patent listed in the FDA Orange Book for an approved product containing Icosapent Ethyl expires 28 Jun 2033. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.

Current records (10)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Icosapent Ethyl. Country is the organisation's recorded country, not necessarily the manufacturing site.

China4South1Norway1France1Germany1Country not recorded for 2
  • SICHUAN GOWELL PHARMACEUTICAL CO LTD
    Active DMF 35854, 43834 · latest filing Mar 2026
  • AK BIOPHARM CO., LTD.
    Active DMF 36822 · latest filing Jun 2022
    South
  • BASF AS
    Active DMF 23911 · latest filing Jul 2010
    Norway Company GMP cert on record
  • CHUNGHWA CHEMICAL SYNTHESIS AND BIOTECH CO LTD
    Active DMF 26271 · latest filing Aug 2012
    Company GMP cert on record
  • FINORGA SAS
    Active DMF 27182 · latest filing May 2013
    France Company GMP cert on record
  • HUATAI PHARMA INC
    Active DMF 34959 · latest filing Jul 2020
    China
  • JIANGSU HAINEKON BIOTECHNOLOGY CO LTD
    Active DMF 36758 · latest filing Feb 2022
    China
  • KD PHARMA BEXBACH GMBH
    Active DMF 26892 · latest filing Feb 2013
    Germany Company GMP cert on record
  • KINOMEGA BIOPHARM INC
    Active DMF 39040 · latest filing Oct 2023
    China
  • Zhejiang Medicine Co., Ltd.
    Active DMF 38870 · latest filing Oct 2023
    China
Need Icosapent Ethyl sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Historical records (2)

Organisations whose Type II DMFs for Icosapent Ethyl are no longer active. These show a past filing, not current supply.

Show all 2 historical records
  • Japan · Inactive DMF 30188 · filed Jun 2016
  • SKUNY BIOSCIENCE CO LTD
    Inactive DMF 28422 · filed Jun 2014

US product patents and exclusivity

The FDA Orange Book lists patents and exclusivities for specific approved products (21 listed products contain Icosapent Ethyl). The latest listed patent expires 28 Jun 2033. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.

Overview

Icosapent Ethyl is an ethyl ester of eicosapentaenoic acid (EPA), an omega-3 fatty acid that is used to lower triglyceride levels in adults with severe hypertriglyceridemia. It is a prescription medication that has been shown to reduce the risk of cardiovascular events.

Chemical identity

IUPAC name
ethyl (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate
Canonical SMILES
CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)OCC
InChIKey
SSQPWTVBQMWLSZ-AAQCHOMXSA-N
Synonyms
Vascepa API, amr 101, amr-101, amr101, eicosapentaenoic acid ethyl ester, epadel, ethyl icosapent, ethyl icosapentate, icosapent ethyl ester, nsc-759597, timnodonic acid ethyl ester, vascepa

Therapeutic areas

CardiovascularLipid Metabolism DisordersDiabetes

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Icosapent Ethyl?

10 organisations hold an active US FDA Type II Drug Master File or a CEP for Icosapent Ethyl: SICHUAN GOWELL PHARMACEUTICAL CO LTD, AK BIOPHARM CO., LTD. (South), BASF AS (Norway), CHUNGHWA CHEMICAL SYNTHESIS AND BIOTECH CO LTD, FINORGA SAS (France), HUATAI PHARMA INC (China), JIANGSU HAINEKON BIOTECHNOLOGY CO LTD (China) and KD PHARMA BEXBACH GMBH (Germany), and 2 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Icosapent Ethyl Drug Master Files are active?

SICHUAN GOWELL PHARMACEUTICAL CO LTD (DMF 35854, 43834), AK BIOPHARM CO., LTD. (DMF 36822), BASF AS (DMF 23911), CHUNGHWA CHEMICAL SYNTHESIS AND BIOTECH CO LTD (DMF 26271), FINORGA SAS (DMF 27182), HUATAI PHARMA INC (DMF 34959), JIANGSU HAINEKON BIOTECHNOLOGY CO LTD (DMF 36758) and KD PHARMA BEXBACH GMBH (DMF 26892) and 2 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Icosapent Ethyl records mean?

2 organisations have only inactive Type II DMFs for Icosapent Ethyl. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does the FDA Orange Book list patents for products containing Icosapent Ethyl?

Yes. The latest patent listed for an approved US product containing Icosapent Ethyl expires 28 Jun 2033, across 21 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.

How do I qualify a Icosapent Ethyl supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Icosapent Ethyl?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.